Shares of Healios K.K. (OTCMKTS:HLOSF – Get Free Report) fell 28.9% during mid-day trading on Thursday . The company traded as low as $0.96 and last traded at $0.96. 100 shares changed hands during trading, a decline of 96% from the average session volume of 2,332 shares. The stock had previously closed at $1.35.
Healios K.K. Stock Performance
The stock has a 50 day moving average of $1.35 and a 200-day moving average of $1.39.
Healios K.K. Company Profile
Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.
Further Reading
- Five stocks we like better than Healios K.K.
- How to Start Investing in Real Estate
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
- The How and Why of Investing in Gold Stocks
- Nebius Group: The Rising Star in AI Infrastructure
- What to Know About Investing in Penny Stocks
- MarketBeat Week in Review – 12/30 – 1/03
Receive News & Ratings for Healios K.K. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healios K.K. and related companies with MarketBeat.com's FREE daily email newsletter.
